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An autosomal recessive ichthyosis characterized by col-
lodian membrane at birth followed by generalized skin
redness and fine, light-colored scales has been termed
nonbullous congenital ichthyosiform erythroderma
(CIE). CIE has often been classified together with the
other major form of recessive ichthyosis without internal
organ involvement, lamellar ichthyosis, which is charac-
terized by minimal erythema and a coarser, darker scale
pattern. Recently, autosomal recessive ichthyosis has been
associated with keratinocyte transglutaminase (TGase1)
defects in some patients. This group of diseases, however,
is genetically heterogeneous and TGase1 abnormalities
in CIE have not been clearly described. Therefore we
examined TGase1 expression in five patients with CIE and
three with classic lamellar ichthyosis. Although lamellar
ichthyosis patients displayed no TGase1 expression, an
abnormal intracellular accumulation of TGase1 was
The ichthyoses include several disorders of epidermaldifferentiation (Williams and LeBoit, 1996). Whereasseveral of these disorders are associated with systemicfindings, the autosomal recessive ichthyoses (MendelianInheritance in Man, no. 242100) demonstrate only skin
findings (Williams and LeBoit, 1996). Infants born with a shiny,
generalized hyperkeratosis known as a collodian membrane may
subsequently develop one of several different clinical phenotypes. The
severe classic lamellar ichthyosis (LI) phenotype is characterized by
large brown thick scales with a plate-like appearance over the entire
body surface combined with eyelid ectropion (Williams and Elias,
1996). Erythema in these patients is typically modest and masked by the
overlying scales. The other phenotype, previously termed nonbullous
congenital ichthyosiform erythroderma (CIE) (Williams and Elias,
1996), is characterized by smaller and lighter scales, typically on a
background of generalized skin redness. The CIE phenotype is,
in general, more variable with respect to severity and prognosis.
Histologically, LI is characterized by massive orthohyperkeratosis
whereas CIE may occasionally exhibit areas of parakeratosis in thickened
stratum corneum. Moreover, whereas LI epidermal cell kinetics are in
the normal range, CIE exhibits hyperproliferation (Hazell and Marks,
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observed in four of five CIE patients. This finding was
specific and was not observed in other skin disorders
characterized by erythema and abnormal cornification,
including erythrodermic psoriasis, atopic dermatitis,
epidermolytic hyperkeratosis, and Netherton’s syndrome.
CIE keratinocytes with abnormal TGase1 localization
expressed full-length TGase1 mRNA and protein but
demonstrated transglutaminase activity intermediate
between normal and the minimal activity seen in lamellar
ichthyosis patient cells. The abnormal TGase1 expression
pattern and CIE clinical features were recapitulated in
epidermis regenerated in vivo on immune deficient mice
from CIE patient keratinocytes. These studies describe a
specific abnormality in TGase1 intrinsic to keratinocytes
in a subset of CIE patients and suggest that this abnorm-
ality may be involved in the disordered epidermal
differentiation seen in this disorder. Key words: differenti-
ation/gene expression/skin. J Invest Dermatol 110:8–12, 1998
1985). Ultrastructural differences in stratum corneum membrane lipids
are also evident between LI and CIE (Ghadially et al, 1992). Neverthe-
less, differentiation between the two phenotypes in the postnatal period
can be problematic and distinguishing clinical features may not develop
until later in childhood, with no predictive diagnostic test available
to date.
Mutations in the keratinocyte transglutaminase gene (TGM1) have
been identified in several patients with autosomal recessive ichthyosis
(Russell et al, 1994, 1995; Huber et al, 1995a). Located on chromosome
14q, TGM1 encodes keratinocyte transglutaminase (TGase1) (Thacher
et al, 1985), an enzyme responsible for Nε-γ-glutamyl isodipeptide
cross-linking of precursors of the cornified envelope. TGase1 is a
member of a family of six transglutaminases, two others of which are
expressed in the skin, the ubiquitous tissue TGase2 and the skin-
specific cytosolic epidermal Tgase3 (Greenberg et al, 1991; Kim et al,
1995a). Whereas the latter has been shown capable of cross-linking
cornified envelope substrates, TGase1 is the major transglutaminase
responsible for the overwhelming majority of this activity in human
skin (Kim et al, 1995a). In support of this, the total transglutaminase
activity in keratinocytes from autosomal recessive ichthyosis patients
that lack TGase1 is reduced to near background levels (Huber et al,
1995a). These observations, combined with the fact that TGase3 resides
at a separate, unlinked chromosomal locus from TGase1, indicate
that TGase1 is the major transglutaminase involved in epidermal
differentiation (Greenberg et al, 1991; Kim et al, 1995a). TGase1 cross-
links substrates involved in forming the insoluble, 10–20 nm cornified
envelope that forms on the cytoplasmic surface of the plasma membrane
as keratinocytes undergo terminal differentiation. These substrates
include proteins such as loricrin, involucrin, elafin, filaggrin, and
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keratin intermediate filaments and are deposited in a complex aggregate
divisible biochemically into three distinct layers (Hohl et al, 1995;
Steinert and Marekov, 1995). TGase1 loss in LI is associated with
abnormal cornified envelope formation and defective barrier function
(Hohl et al, 1993; Lavrijsen et al, 1993); the resultant hyperkeratotic
clinical disease may result from inappropriate compensatory signals for
epidermal differentiation (Roop, 1995).
Whereas TGase1 loss may explain features of the pathogenesis of
ichthyosis (Roop, 1995), the basis for the phenotypic heterogeneity of
these disorders remains to be elucidated. A recent large linkage analysis
of autosomal recessive ichthyosis identified linkage to the TGM1 locus
in only 10 of 23 families (Parmentier et al, 1995). Moreover, at least
some autosomal recessive ichthyosis families have demonstrated no
TGM1 linkage and normal TGase1 protein expression (Huber et al,
1995b). The lack of clear clinical descriptions in some series leaves
unanswered the question of whether differences in TGase1 involvement
contribute to development of LI and CIE phenotypes. To address this
issue, we have examined TGase1 expression in patients with the CIE
as well as classic LI phenotypes along with patients with other skin
disorders characterized by abnormal epidermal differentiation. Here
we describe abnormal expression of TGase1 in CIE and suggest that
this abnormality may be specific for a subset of CIE patients.
MATERIALS AND METHODS
Patient selection and clinical classification Patients were included in this
study if they fulfilled previously published criteria for autosomal recessive
ichthyosis; these included the presence of a collodian membrane at birth
followed by the development of a disorder of cornification characterized as
either the classic LI or the CIE phenotype (Williams and Elias, 1996; Williams
and LeBoit, 1996). Patients were characterized as having the LI phenotype in
the setting of a history of a collodian membrane at birth, large plate-like
hyperkeratotic scales with marked ectropion, and mild-to-no skin erythema.
The CIE phenotype encompassed patients noted to have a collodian membrane
at birth demonstrating subsequent erythema and fine light scales in a generalized
distribution that included the face and all flexural surfaces; facial involvement
included ectropion and/or facial tautness. All of these autosomal recessive
ichthyosis patients have been followed clinically by one of us (M.L.W.) for 2 y
or more; none of their families were directly related or shared distinctive ethnic
backgrounds and no consanguinity or multigenerational involvement was
present. Only patients were included whose skin disorder was not attributable
to any other cutaneous condition or to a systemic syndrome. Regarding the
latter, our patients lacked any systemic findings, including the specific neurologic,
ocular, skeletal, and metabolic abnormalities characteristic of other recessive
ichthyoses, such as X-linked ichthyosis, Refsum’s disease, Sjogren–Larsson’s
disease, the Chararin–Dorfman syndrome, or Rud’s syndrome. In addition,
patients lacked a history of skin blistering and displayed no laboratory abnorm-
alities indicative of any other disorder; these included normal white blood cell
morphology on peripheral blood smear and normal plasma cholesterol sulfate
levels in male patients. Patients analyzed had received no specific systemic or
topical therapy (i.e., retinoids) within the past year. Control patients included
those with normal skin as well as the following disorders of abnormal
cornification and/or skin erythema: erythrodermic psoriasis, atopic dermatitis,
Netherton’s syndrome, and epidermolytic hyperkeratosis.
Skin biopsy and keratinocyte culture Six millimeter punch biopsies were
taken from the skin of patients with autosomal recessive ichthyosis in accordance
with IRB-approved protocols at Stanford and UCSF. Primary keratinocytes
were isolated and cultured as described previously (Rheinwald and Green, 1975).
Immunohistochemical analysis and laser confocal microscopy Patient
skin biopsies were obtained and frozen sections fixed in acetone then stained
with rabbit polyclonal antibodies raised against synthetic peptides from the
amino and carboxy terminus of TGase1 (Rice, 1994), as well as a goat polyclonal
anti-serum specific for human TGase1 (Kim et al, 1995b) and monoclonal
antibody to human TGase1 (Thacher et al, 1985). Sections were incubated with
primary antibody, washed three times with phosphate-buffered saline then
incubated with fluoroscein isothiocyanate-conjugated secondary antibody prior
to repeat washing and analysis via fluorescence microscopy. Sections were also
stained and analyzed via laser confocal microscopy. For biopsies of regenerated
human CIE and normal control skin xenografts, species-specific antibodies to
human TGase1 also served to confirm the human origin of the graft.
Transglutaminase assay Early passage keratinocytes were grown to conflu-
ence in a 1:1 mixture of SFM/154 media (Gibco/Cascade Biologics, Grand
Figure 1. Clinical appearance of patients with autosomal recessive
ichthyosis, congenital ichthyosiform erythroderma, and lamellar
ichthyosis phenotypes. (a) In the congenital ichthyosiform erythroderma
phenotype, erythema and fine white scales are noted. (b) The classic lamellar
ichthyosis phenotype is characterized by minimal erythema and large, thick
brown scales.
Island, NY) then media calcium concentration raised to 1.2 mM for 48–72 h
to induce TGase1 expression. Whole cell extracts were then prepared and
transglutaminase assay performed as described previously (Rice, 1994). Protein
concentration was determined in each sample by Bradford analysis (Biorad,
Emeryville, CA), data normalized to protein concentration (cpm per mg 3
10–4) and then expressed as a percentage of the activity in control keratinocytes
isolated from patients with normal skin and grown under identical conditions.
Measured transglutaminase values varied between experiments, with 36.7 6 0.79
cpm per mg 3 10–3 as an approximate average value.
Western analysis Cell extracts prepared for transglutaminase assay above
were subjected to denaturing gel electrophoresis on an 8% polyacrylamide gel,
using µ20 µg of extract protein per lane. After electrophoresis, protein was
transferred to nitrocellulose membrane and incubated with polyclonal antibodies
to human TGase1 (Rice et al, 1992). The blot was simultaneously probed with
antibodies to human BRG1 (Khavari et al, 1993; Kwon et al, 1994), a
constituitively expressed cellular protein that served as an additional control of
cell extract quality, protein concentration, and transfer efficiency.
Regeneration of human CIE skin on immunodeficient mice CIE
patient keratinocytes grown in dispersed culture in vitro as well as normal
controls were used to regenerate human epidermis in vivo on nude mice using
a devitalized dermal substrate as described previously (Medalie et al, 1996;
Choate et al, 1996b).
RESULTS
Characteristics of patients with CIE A series of patients with
autosomal recessive ichthyosis with either the classic LI phenotype
(three patients) or the erythrodermic CIE phenotype (five patients)
were studied. Two of the patients were siblings. Representative
photographs of our patients with CIE and LI are shown in Figs 1a
and 1b, respectively. These patients underwent skin biopsy after
complete history and physical examination. Each skin biopsy was
divided and a portion utilized for immunofluorescence analysis with
the remainder used to grow keratinocytes in culture as previously
described (Rheinwald and Green, 1975). These autosomal recessive
ichthyosis patients provided the basis for the studies noted below.
Abnormal TGase1 expression in a subset of CIE patients Only
a subset of patients with autosomal recessive hyperkeratotic skin
disorders broadly defined as autosomal recessive ichthyosis demonstrate
genetic linkage to the TGM1 gene or abnormal TGase1 expression
(Huber et al, 1995b; Parmentier et al, 1995). In order to evaluate
TGase1 expression in the two major differing phenotypes of autosomal
recessive ichthyosis without systemic involvement, immunofluores-
cence microscopy with monoclonal (Thacher et al, 1985) and polyclonal
(Rice et al, 1992; Kim et al, 1995a) antibodies to human TGase1 was
performed. In all the normal controls, TGase1 expression was localized
in a continuous pattern most prominent in the outer epidermis (Fig 2a)
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Figure 2. Abnormal subcellular localization of TGase1 in CIE patient
skin. Laser confocal immunofluorescence microscopy was performed with
antibodies to human TGase1 on skin tissue obtained from (a) normal skin
control and (b) CIE patient skin. (c) Background skin tissue immunofluorescence
seen with no primary antibody to TGase1. (d) Histology of CIE patient skin.
Note the increase in stratum corneum thickness and absence of parakeratosis.
BMZ, basement membrane zone; SC, stratum corneum; SG, stratum
granulosum; S, stratum spinosum.
as previously described, whereas it was entirely absent in our three
patients with the classic LI phenotype (Choate et al, 1996a). Whereas
one of our five patients with the CIE clinical phenotype demonstrated
a normal TGase1 expression pattern, the remaining four CIE patients
demonstrated a distinctive cytoplasmic accumulation of TGase1 expres-
sion in the granular layer and inner stratum corneum of the epidermis
(Fig 2b). This pattern was consistent among these four CIE patients
demonstrating such abnormal TGase1 expression. This TGase1 accu-
mulation did not correspond to nonspecific staining due to parakeratosis,
as demonstrated both by hematoxylin and eosin staining of immuno-
stained CIE patient skin as well as the fact that this finding was not
observed in the parakeratotic stratum corneum of lesional psoriasis skin
(Fig 2d and data not shown, respectively). This abnormal TGase1
pattern was seen across a spectrum of clinical severity of erythema,
from moderate to severe in our CIE patients, and was consistently
present in separate biopsies taken months apart from different body
sites of the same CIE patient. The single CIE patient exhibiting a
normal TGase1 pattern was severely erythrodermic and clinically
indistinguishable from the more severely affected patients displaying
the focal pattern, supporting the existence of further heterogeneity
even within the CIE phenotype. To further examine the specificity of
this TGase1 expression pattern and to determine if this abnormal
expression pattern was due to nonspecific changes in TGase1 expression
due to cutaneous inflammation or hyperproliferation, we performed
TGase1 immunostaining on lesional specimens from patients with
erythrodermic psoriasis, atopic dermatitis, Netherton’s syndrome, and
epidermolytic hyperkeratosis. In none of these disorders was the
distinctive focal accumulation of TGase1 expression identified in our
subset of CIE patients observed, indicating that this finding is specific.
Transglutaminase activity in the CIE patient subset To deter-
mine if the abnormally localized TGase1 seen in the subset of CIE
patients is enzymatically active, extracts from CIE, LI, and normal
keratinocytes were assayed for transglutaminase activity as previously
described (Rice, 1994; Choate et al, 1996a). Whereas classic LI patients
lacking TGase1 demonstrated low transglutaminase activity at levels
near background, keratinocytes isolated from our subset of CIE patients
displaying abnormal TGase1 expression demonstrated transglutaminase
Figure 3. Transglutaminase expression and enzymatic activity in CIE
patient keratinocytes. (a) Transglutaminase assay was performed on cell
extracts prepared from primary CIE patient keratinocytes grown in vitro in the
presence of 1.2 mM calcium as well as those from normal and LI patients prepared
under identical conditions. Transglutaminase activity (cpm per mg 3 10–4)
is expressed as a percentage of normal control. (b) Western blot analysis was
performed using antibodies to human TGase1. Cell extracts from primary CIE
and normal (NL) patient keratinocytes prepared above were subjected to
denaturing gel electrophoresis on an 8% polyacrylamide gel; µ20 µg of protein
was loaded per lane. The blot was simultaneously incubated with antibodies to
the constituitively expressed BRG1 protein as an internal control for efficiency
of protein transfer. Lanes are juxtaposed from previously separated lanes from
the same gel.
activity that was intermediate between the activity in LI and that found
in keratinocytes from normal skin, with representative data shown in
Fig 3a. This magnitude of this activity, although consistently less than
normal for all CIE patients in this subset, was extremely variable
among cell preparations from the same patient. CIE keratinocyte
transglutaminase activity displayed no consistent abnormalities in
distribution between particulate and soluble cell fractions (data not
shown). TGase1 is proteolytically processed to smaller subunits that
differ in enzymatic activity from the full-length protein. In light of
this, we performed western blot analysis to look for the presence of
major alterations in the size of expressed TGase1 protein in this CIE
subset. Although more difficult to consistently detect compared with
normal, TGase1 protein in the CIE subset appeared similar in size to
that found in normal keratinocytes (Fig 3b). Higher percentage gels
and three different, separately raised polyclonal anti-sera to
TGase1 (Rice et al, 1992; Kim et al, 1995a) were utilized in an effort
to detect any smaller proteolytic fragments; none were found and
normal size TGase1 mRNA species were detected at physiologic levels
in these CIE keratinocytes (data not shown).
Recapitulation of the CIE phenotype in human skin regenerated
from CIE keratinocytes The primary defect in cutaneous disorders
of hyperproliferation and hyperkeratosis may be intrinsic either to the
epidermis, such as mutations in suprabasal keratins in epidermolytic
hyperkeratosis (Cheng et al, 1992; Rothnagel et al, 1992), or to
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Figure 4. The CIE phenotype is maintained
in skin regenerated from CIE patient
keratinocytes grown in vitro. CIE and normal
keratinocytes were grown in vitro from patient
skin biopsies and then grafted on immuno-
deficient mice. The clinical appearance of human
skin regenerated from CIE patient keratinocytes
(a, b) as well as normal controls (c, d) is shown
at 7 wk postgrafting. (e) Histologic appearance
of regenerated CIE and normal patient skin.
BMZ, basement membrane zone; SC, stratum
corneum.
extracutaneous influences as seen with the immunobiologic factors
proposed important in the pathogenesis of psoriasis (Gottlieb et al,
1995). To distinguish between these possibilities, we determined if
transfer of pure keratinocyte populations lacking in CIE host immune,
vascular, and mesenchymal influences could recapitulate prominent
disease features of CIE in vivo. To accomplish this, we regenerated
human skin on immunodeficient mice using keratinocytes purified
from CIE patients as well as normal controls. Whereas a carryover of
some melanocytes has been described in the model we utilized (Medalie
et al, 1996) and can result in graft pigmentation in the case of donors
with heavily pigmented skin (Choate et al, 1996b; Medalie et al, 1996),
passage in vitro under the stringent conditions utilized effectively
eliminates all other cells of nonepidermal origin. In spite of the fact
that anatomic and metabolic features of murine and human host tissue
differ significantly, human epidermis regenerated on immunodeficient
mice from CIE patient keratinocytes displayed erythema and marked
hyperkeratosis in vivo whereas normal control epidermis did not
(Fig 4a–d); differences seen in pigmentation are due to melanocyte
carryover in this model (Medalie et al, 1996) and reflect the degree of
pigmentation of the CIE and normal donors. Skin regenerated from
normal keratinocytes demonstrated a normal pattern of TGase1 expres-
sion by immunostaining. Regenerated grafted CIE skin, however,
displayed the abnormal TGase1 pattern observed in skin directly
obtained from CIE patients (data not shown), demonstrating the
stability of this tissue abnormality, and its cell-intrinsic in nature.
DISCUSSION
Precise subcellular localization is a requirement for proper function of
many intracellular proteins. Knowledge of protein localization and
trafficking within the cell has advanced significantly in recent years.
An example of a human disease involving abnormal intracellular
expression of a potentially biologically active protein is the ∆F508
mutation in the cystic fibrosis conductance transmembrane regulator.
Whereas the ∆F508 cystic fibrosis conductance transmembrane regu-
lator can function as a cAMP-activated chloride channel, this mutated
cystic fibrosis conductance transmembrane regulator accumulates in a
pre-Golgi compartment and is degraded before it reaches the plasma
membrane (Dalemans et al, 1991; Denning et al, 1992; Ward et al,
1995). This block in correct protein targeting within the cell can be
overcome at reduced temperatures where expression of ∆F508 mole-
cules forming functional chloride channels at the plasma membrane
can be achieved (Denning et al, 1992). Here we have described the
association of abnormally expressed TGase1 in a subset of patients
with CIE. The presence of a pattern of focal intracellular TGase1
accumulation in a majority of our patients with this clinical presentation
but not in other patients with a range of hyperkeratotic and
erythematous skin disorders suggests that this aberrant distribution
is specific.
The regulation of TGase1 activity is a complex process with control
mechanisms at the level of mRNA expression, protein translation, and
post-translational modification (Kim et al, 1995b; Gibson et al, 1996).
The latter requires addition of lipid moieties for membrane anchorage,
a process that affects partitioning between cytosolic and membrane
fractions (Steinert et al, 1996) and is dependent on a cluster of five
cysteine residues at the amino terminus of the protein (Phillips et al,
1993; Steinert et al, 1996). An intrinsic defect in the TGase1 sequence
in our CIE patients within these amino acid sequences involved in
membrane localization could provide a possible explanation for our
observed findings. DNA sequencing of the region spanning TGase1
amino acids 1–91, which contains the five cysteine cluster implicated
in membrane targeting (Phillips et al, 1993), in multiple clones from
our affected CIE subset patients, however, has demonstrated no
mutations (K. Choate and P. Khavari, unpublished). The majority of
transglutaminase enzymatic activity found in differentiating keratino-
cytes is due to TGase1 (Kim et al, 1995a) with 70–90% of the total
activity present in membrane-containing particulate cell extract fractions
and the remainder in the soluble portion. In support of this physiologic
membrane association, the majority of immunoreactive TGase1 protein
in differentiated layers of human skin is found at the cell periphery.
Although total loss of TGase1 function, as seen in LI, is associated
with a severe cutaneous phenotype, it is possible that abnormal focal
expression of enzymatically active TGase1 could also result in a
pathogenic disruption in epidermal differentiation as well. In summary,
we have identified a specific, cell-intrinsic pattern of focal intracellular
accumulation of partially functional TGase1 in a subset of autosomal
recessive ichthyosis patients with the CIE phenotype.
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